Ajanta Pharma Ltd.

Financial

	Ajanta Pharma	Fortis Healthcare	Sanofi India
Operational Metrics
Pharmaceutical Sector
Number of ANDA's Filed in USA	77.0 .	n/a	n/a
Number of ANDA's Approved By USFDA	55.0 .	n/a	n/a
Domestic Sales Growth - YoY	15.6 %	n/a	0.6 %
R&D as a % of Total Sales	5.0 %	n/a	0.0
Financials
5 yr Average ROE	20.38 %	2.33 %	43.25 %
5yr average Equity Multiplier	1.34	1.73	3.33
5yr Average Asset Turnover Ratio	0.79	0.44	0.57
5yr Avg Net Profit Margin	19.43 %	2.18 %	22.99 %
Price to Book	7.84	4.52	14.97
P/E	34.28	57.82	27.67
5yr Avg Cash Conversion Cycle	-93.41 Days	-133.71 Days	11.11 Days
Inventory Days	61.2 Days	6.17 Days	48.47 Days
Days Receivable	52.69 Days	31.7 Days	13.83 Days
Days Payable	198.04 Days	220.67 Days	55.71 Days
5yr Average Interest Coverage Ratio	108.17	3.83	1007.93
5yr Avg ROCE	25.98 %	4.56 %	29.56 %
5yr Avg Operating Profit Margin	30.03 %	14.05 %	28.62 %
5 yr average Debt to Equity	0.0	0.19	0.0
5yr CAGR Net Profit	11.78 %	n/a	41.96 %
5yr Average Return on Assets	15.32 %	1.32 %	13.01 %
Shareholdings
Promoter Holding	66.21 %	31.17 %	60.4 %
Share Pledged by Promoters	12.26 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	-4.13 %	0.0	0.0
Change in Mutual Fund Holding (3 Yrs)	5.23 %	14.26 %	1.86 %

Business

	Ajanta Pharma	Fortis Healthcare	Sanofi India
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Out-Patient Services 0 In-Patient Services 0 Pharmaceuticals 0	Product Wise Break-Up Out-Patient Services 13.51 Pharmaceuticals 0 In-Patient Services 85.57 Pharmaceutical 0 Others 0.92	Product Wise Break-Up Out-Patient Services 0 Pharmaceutical 100.0 In-Patient Services 0 Pharmaceutical 0
Segment Break-Up	Segment Break-Up Diagnostics 0 Healthcare 0 Others 100	Segment Break-Up Healthcare 81.49 Diagnostic Services 18.51	-
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Orthopedics 0 Renal 0 Neuro & Spine 0 Gastro 0 Oncology 0 Pulmonology 0 Gynecology 0 Cardiac 0 RESPIRATORY 0 DERMA 0 ANTI-INFECTIVES 0 GASTRO INTESTINAL 0 NEURO/CNS 0 PAIN/ANALGES 0 CARDIAC 0 ANTI DIABETIC 0 VMN 0 Others 100	Therapeutic Area Wise Break-Up - Domestic Gastro Intestinal 5.2 ANTI DIABETIC 0 Oncology 14.3 GASTRO INTESTINAL 0 VMN 0 Orthopaedics 8.7 Pulmonology 2.9 Gynecology 3.6 ANTI-INFECTIVES 0 NEURO/CNS 0 PAIN/ANALGES 0 Renal 7.3 Cardiac Science 17.8 RESPIRATORY 0 Central Nervous System (CNS) 8.5 DERMA 0 CARDIAC 0 Others 31.7	Therapeutic Area Wise Break-Up - Domestic Gastro 0 Anti - Diabetes 38.81 Oncology 0 Gastro Intestinal 10.56 VMN 0 Orthopedics 0 Pulmonology 0 Gynecology 0 Anti-Infective 5.72 Central Nervous System (CNS) 6.86 Pain Management 7.15 Renal 0 Cardiac 0 Respiratory Systems 13.48 Neuro & Spine 0 DERMA 0 Cardiac Science 17.42
Location Wise Break-Up	Location Wise Break-Up India 30.93 Asia Pacific 26.66 USA 24.76 Africa 16.51 Rest of the World 0 South India 0 East India 0 West India 0 North India 0 Singapore 0 Others 1.14	Location Wise Break-Up USA 0 India 0 West India 21.0 Singapore 0 South India 28.0 Africa 0 Asia Pacific 0 East India 14.0 North India 34.0 Rest of the World 3.0	Location Wise Break-Up USA 0 India 81.47 West India 0 Singapore 17.88 South India 0 Africa 0 Asia Pacific 0 East India 0 North India 0 Rest of the World 0 Others 0.65
Asset Break-Up	Asset Break-Up India 99.11 USA 0.51 Asia Pacific 0.29 Africa 0.08 Others 0.01	Asset Break-Up Africa 0 Asia Pacific 0 USA 0 India 98.91 Others 1.09	-

Ajanta Pharma Ltd.

SIGN UP FOR FREE